Publications by authors named "Angelo Willems"

Claim this Profile
I
Inhibition of p38alpha mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myeloma.
Karin Vanderkerken, Satya Medicherla, Les Coulton, Hendrik De Raeve, Angelo Willems

Cancer Res· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 5T2MM murine model of multiple myeloma: maintenance and analysis.
Karin Vanderkerken, Kewal Asosingh, Angelo Willems, Hendrik De Raeve, Pedro Couck

Methods Mol Med· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression.
Kewal Asosingh, Hendrik De Raeve, Mark de Ridder, Guy A Storme, Angelo Willems

Haematologica· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed in vivo disease progression is associated with high proportions of CD45+ myeloma cells in the 5T2MM murine model.
Kewal Asosingh, Angelo Willems, Ivan Van Riet, Benjamin Van Camp, Karin Vanderkerken

Cancer Res· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma.
Karin Vanderkerken, Evy De Leenheer, Claire Shipman, Kewal Asosingh, Angelo Willems

Cancer Res· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis